Rac Elizabeth Keiper

Elizabeth Keiper, RAC has a diverse range of work experience in the field of regulatory affairs. Elizabeth most recently worked at Sage Therapeutics as the Director of Regulatory Affairs, a position they have held since March 2021. Prior to that, they served as the Associate Director of Regulatory Affairs at Sage Therapeutics from May 2018 to March 2021.

Before joining Sage Therapeutics, Elizabeth worked at Akebia Therapeutics as an Associate Director of Regulatory Affairs from December 2015 to April 2018. Elizabeth also had a brief role at Tokai Pharmaceuticals, Inc. as a Senior Manager of Regulatory Affairs and Quality Assurance from March 2015 to November 2015.

Elizabeth's previous experience includes roles at Tokai Pharmaceuticals as a Manager of Regulatory Affairs and Quality Assurance from October 2013 to February 2015, at AVEO Oncology as a Manager of Regulatory Affairs from July 2013 to October 2013, and as a Senior Associate of Regulatory Affairs from November 2011 to June 2013.

Prior to their time at AVEO Oncology, Elizabeth worked as a Regulatory Affairs Specialist at B. Braun Medical from June 2008 to November 2011. Elizabeth began their career at GlaxoSmithKline as a Senior Scientist, where they worked from October 2001 to June 2008.

Overall, Elizabeth Keiper, RAC has built an extensive background in regulatory affairs through their various roles at pharmaceutical and medical companies.

Elizabeth Keiper, RAC completed their Bachelor of Science (BS) degree in Genetic Engineering at Cedar Crest College from 1996 to 2000. Elizabeth later pursued their Master of Science (MS) degree in Quality Assurance/Regulatory Affairs at Temple University, completing it in 2016.